Literature DB >> 24821880

Everything old is new again! Neoadjuvant chemotherapy in the treatment of muscle-invasive bladder cancer.

Cora N Sternberg1, Andrea B Apolo2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24821880     DOI: 10.1200/JCO.2014.55.4055

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  6 in total

Review 1.  [Pharmaceutical treatment of advanced urinary bladder cancer: new developments in 2014].

Authors:  S C Schmid; J E Gschwend; M Retz
Journal:  Urologe A       Date:  2014-10       Impact factor: 0.639

2.  BcCluster: A Bladder Cancer Database at the Molecular Level.

Authors:  Akshay Bhat; Marika Mokou; Jerome Zoidakis; Vera Jankowski; Antonia Vlahou; Harald Mischak
Journal:  Bladder Cancer       Date:  2016-01-07

3.  Determinants of neoadjuvant chemotherapy use in muscle-invasive bladder cancer.

Authors:  Filipe Lf Carvalho; Alexander Zeymo; Jillian Egan; Colleen H Kelly; Chaoyi Zheng; John H Lynch; Jonathan Hwang; Lambros Stamatakis; Ross E Krasnow; Keith J Kowalczyk
Journal:  Investig Clin Urol       Date:  2020-05-26

4.  Neoadjuvant vascular-targeted photodynamic therapy improves survival and reduces recurrence and progression in a mouse model of urothelial cancer.

Authors:  Barak Rosenzweig; Renato B Corradi; Sadna Budhu; Ricardo Alvim; Pedro Recabal; Stephen La Rosa; Alex Somma; Sebastien Monette; Avigdor Scherz; Kwanghee Kim; Jonathan A Coleman
Journal:  Sci Rep       Date:  2021-03-01       Impact factor: 4.379

5.  SEOM-SOGUG clinical guideline for localized muscle invasive and advanced bladder cancer (2021).

Authors:  Begoña P Valderrama; Aránzazu González-Del-Alba; Rafael Morales-Barrera; Ignacio Peláez Fernández; Sergio Vázquez; Cristina Caballero Díaz; Montserrat Domènech; Ovidio Fernández Calvo; Alfonso Gómez de Liaño Lista; José Ángel Arranz Arija
Journal:  Clin Transl Oncol       Date:  2022-03-26       Impact factor: 3.405

6.  Trichlorobenzene-substituted azaaryl compounds as novel FGFR inhibitors exhibiting potent antitumor activity in bladder cancer cells in vitro and in vivo.

Authors:  Chun-Han Chen; Yi-Min Liu; Shiow-Lin Pan; Yun-Ru Liu; Jing-Ping Liou; Yun Yen
Journal:  Oncotarget       Date:  2016-05-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.